Literature DB >> 26310808

Local Anti-miR Delivery: The Latest in the Arsenal of Drug-Eluting Stents.

Kathryn J Moore1, Katey J Rayner2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26310808      PMCID： PMC4617631          DOI： 10.1161/ATVBAHA.115.306187

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN： 1079-5642            Impact factor:   8.311


× No keyword cloud information.
  11 in total

1.  Treatment of drug-eluting stent restenosis the new pilgrimage: quo vadis?

Authors:  Fernando Alfonso
Journal:  J Am Coll Cardiol       Date:  2010-06-15       Impact factor: 24.094

Review 2.  The importance of the endothelium in atherothrombosis and coronary stenting.

Authors:  Fumiyuki Otsuka; Aloke V Finn; Saami K Yazdani; Masataka Nakano; Frank D Kolodgie; Renu Virmani
Journal:  Nat Rev Cardiol       Date:  2012-05-22       Impact factor: 32.419

3.  MicroRNA-21 regulates vascular smooth muscle cell function via targeting tropomyosin 1 in arteriosclerosis obliterans of lower extremities.

Authors:  Mian Wang; Wen Li; Guang-Qi Chang; Cai-Sheng Ye; Jing-Song Ou; Xiao-Xi Li; Yong Liu; Tuck-Yun Cheang; Xue-Ling Huang; Shen-Ming Wang
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-08-04       Impact factor: 8.311

Review 4.  Current treatment of in-stent restenosis.

Authors:  Fernando Alfonso; Robert A Byrne; Fernando Rivero; Adnan Kastrati
Journal:  J Am Coll Cardiol       Date:  2014-03-13       Impact factor: 24.094

5.  Local MicroRNA Modulation Using a Novel Anti-miR-21-Eluting Stent Effectively Prevents Experimental In-Stent Restenosis.

Authors:  Dong Wang; Tobias Deuse; Mandy Stubbendorff; Ekaterina Chernogubova; Reinhold G Erben; Suzanne M Eken; Hong Jin; Yuhuang Li; Albert Busch; Christian-H Heeger; Boris Behnisch; Hermann Reichenspurner; Robert C Robbins; Joshua M Spin; Philip S Tsao; Sonja Schrepfer; Lars Maegdefessel
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-07-16       Impact factor: 8.311

6.  MicroRNA-21 blocks abdominal aortic aneurysm development and nicotine-augmented expansion.

Authors:  Lars Maegdefessel; Junya Azuma; Ryuji Toh; Alicia Deng; Denis R Merk; Azad Raiesdana; Nicholas J Leeper; Uwe Raaz; Anke M Schoelmerich; Michael V McConnell; Ronald L Dalman; Joshua M Spin; Philip S Tsao
Journal:  Sci Transl Med       Date:  2012-02-22       Impact factor: 17.956

7.  MicroRNA expression signature and antisense-mediated depletion reveal an essential role of MicroRNA in vascular neointimal lesion formation.

Authors:  Ruirui Ji; Yunhui Cheng; Junming Yue; Jian Yang; Xiaojun Liu; He Chen; David B Dean; Chunxiang Zhang
Journal:  Circ Res       Date:  2007-05-03       Impact factor: 17.367

Review 8.  MicroRNAs in cardiovascular disease: an introduction for clinicians.

Authors:  Simon P R Romaine; Maciej Tomaszewski; Gianluigi Condorelli; Nilesh J Samani
Journal:  Heart       Date:  2015-03-26       Impact factor: 5.994

9.  Pathologic Etiologies of Late and Very Late Stent Thrombosis following First-Generation Drug-Eluting Stent Placement.

Authors:  Fumiyuki Otsuka; Masataka Nakano; Elena Ladich; Frank D Kolodgie; Renu Virmani
Journal:  Thrombosis       Date:  2012-11-21

10.  miRNA-21 is dysregulated in response to vein grafting in multiple models and genetic ablation in mice attenuates neointima formation.

Authors:  Robert A McDonald; Katie M White; Junxi Wu; Brian C Cooley; Keith E Robertson; Crawford A Halliday; John D McClure; Sheila Francis; Ruifaug Lu; Simon Kennedy; Sarah J George; Song Wan; Eva van Rooij; Andrew H Baker
Journal:  Eur Heart J       Date:  2013-03-25       Impact factor: 29.983
View more
  1 in total

1.  Drug-Eluting Stent Targeting Sp-1-Attenuated Restenosis by Engaging YAP-Mediated Vascular Smooth Muscle Cell Phenotypic Modulation.

Authors:  Chen Huang; Jie Zhao; Yuelin Zhu
Journal:  J Am Heart Assoc       Date:  2019-12-27       Impact factor: 5.501
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.